BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

Tamer Inanc

Tamer Inanc contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
eess.SYphysics.soc-phPopulations and EvolutionQuantitative MethodsSystems and Control

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
5topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2020arXiv

Optimal Scheduling of Anticipated COVID-19 Vaccination: A Case Study of New York State

This study aims to determine an optimal control strategy for vaccine scheduling in COVID-19 pandemic treatment by converting widely acknowledged infectious disease model named SEIR into an optimal control problem. The problem is augmented by adding medication and vaccine limitations to match real-world situations. Two version of the problem is formulated to minimize the number of infected individuals at the same provide the optimal vaccine possible to reduce the susceptible population to a considerably lower state. Optimal control problems are solved using RBF-Galerkin method. These problems are tested with a benchmarking dataset to determine required parameters. After this step, problems are tested with recent data for New York State, USA. The results regarding the proposed optimal control problem provides a set of evidences from which an optimal strategy for vaccine scheduling can be chosen, when the vaccine for COVID-19 will be available.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Semi-Blind and l1 Robust System Identification for Anemia Management

Chronic diseases such as cancer, diabetes, heart diseases, chronic kidney disease (CKD) require a drug management system that ensures a stable and robust output of the patient's condition in response to drug dosage. In the case of CKD, the patients suffer from the deficiency of red blood cell count and external human recombinant erythropoietin (EPO) is required to maintain healthy levels of hemoglobin (Hb). Anemia is a common comorbidity in patients with CKD. For an efficient and robust anemia management system for CKD patients instead of traditional population-based approaches, individualized patient-specific approaches are needed. Hence, individualized system (patient) models for patient-specific drug-dose responses are required. In this research, system identification for CKD is performed for individual patients. For control-oriented system identification, two robust identification techniques are applied: (1) l1 robust identification considering zero initial conditions and (2) semi-blind robust system identification considering non-zero initial conditions. The EPO data of patients are used as the input and Hb data is used as the output of the system. For this study, individualized patient models are developed by using patient-specific data. The ARX one-step-ahead prediction technique is used for model validation at real patient data. The performance of these two techniques is compared by calculating minimum means square error (MMSE). By comparison, we show that the semi-blind robust identification technique gives better results as compared to l1 robust identification.

0 citations0 reviewsNo code linkedOpen access